{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:22:00Z","timestamp":1790803320710,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"DOI":"10.1007\/s11883-026-01437-9","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:39:09Z","timestamp":1781494749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC\/AHA Multisociety Guideline"],"prefix":"10.1007","volume":"28","author":[{"given":"Dmitry","family":"Abramov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Mannan Khan","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera A.","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaPrincess C.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Gianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandita","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Slipczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"1437_CR1","volume":"101064","author":"GW Hafzalla","year":"1990","unstructured":"Hafzalla GW, Abramov D, Shapiro MD, Minhas AMK. A comparative analysis of cardiovascular disease mortality trends attributable to risk factors in the United States and globally from 1990 to 2019: an analysis of the global burden of disease study 2019. Am J Prev Cardiol. 1990;101064:101064.","journal-title":"Am J Prev Cardiol"},{"key":"1437_CR2","unstructured":"Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, et al. 2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. JACC. Elsevier; 2026."},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73:e285-350 (American College of Cardiology Foundation Washington DC).","journal-title":"J Am Coll Cardiol"},{"key":"1437_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jamapediatrics.2021.2046","volume":"175","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Woo JG, Urbina EM, Jacobs DR Jr, Moran AE, De Ferranti SD. Low-density lipoprotein cholesterol trajectories and prevalence of high low-density lipoprotein cholesterol consistent with heterozygous familial hypercholesterolemia in US children. JAMA Pediatr. 2021;175:1071\u20134.","journal-title":"JAMA Pediatr"},{"key":"1437_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11883-015-0491-z","volume":"17","author":"A Brautbar","year":"2015","unstructured":"Brautbar A, Leary E, Rasmussen K, Wilson DP, Steiner RD, Virani S. Genetics of familial hypercholesterolemia. Curr Atheroscler Rep. 2015;17:20 (Springer).","journal-title":"Curr Atheroscler Rep"},{"key":"1437_CR6","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ES, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43:3925\u201346 (Oxford University Press US).","journal-title":"Eur Heart J."},{"key":"1437_CR7","first-page":"27","volume":"84","author":"C Bess","year":"2024","unstructured":"Bess C, Mehta A, Joshi PH. All we need to know about lipoprotein (a). Prog Cardiovasc Dis Elsevier. 2024;84:27\u201333.","journal-title":"Prog Cardiovasc Dis Elsevier"},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.124.068885","volume":"150","author":"D De Oliveira-Gomes","year":"2024","unstructured":"De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A, Navar AM. Apolipoprotein B: bridging the gap between evidence and clinical practice. Circulation. 2024;150:62\u201379 (Lippincott Williams & Wilkins Hagerstown, MD).","journal-title":"Circulation."},{"key":"1437_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","volume":"77","author":"CDL Johannesen","year":"2021","unstructured":"Johannesen CDL, Mortensen MB, Langsted A, Nordestgaard BG. Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients. J Am Coll Cardiol. 2021;77:1439\u201350 (American College of Cardiology Foundation Washington DC).","journal-title":"J Am Coll Cardiol"},{"key":"1437_CR10","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1001\/jama.2026.2986","volume":"335","author":"S Luebbe","year":"2026","unstructured":"Luebbe S, Sniderman AD, Moran AE, Wilkins JT, Kohli-Lynch CN. Cost-effectiveness of apoB, non\u2013HDL-C, and LDL-C goals for primary prevention lipid-lowering therapy. JAMA. 2026;335:1507\u201314 (American Medical Association).","journal-title":"JAMA"},{"key":"1437_CR11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archinternmed.2012.3708","volume":"172","author":"D Sidhu","year":"2012","unstructured":"Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med. 2012;172:1707\u201310 (American Medical Association).","journal-title":"Arch Intern Med"},{"key":"1437_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2796.2010.02333.x","volume":"270","author":"A Langsted","year":"2011","unstructured":"Langsted A, Freiberg J, Tybj\u00e6rg-Hansen A, Schnohr P, Jensen GB, Nordestgaard B. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen city heart study with 31 years of follow-up. J Intern Med. 2011;270:65\u201375.","journal-title":"J Intern Med"},{"key":"1437_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American heart association\u2019s PREVENT equations. Circulation. 2024;149:430\u201349 (Lippincott Williams & Wilkins Hagerstown, MD).","journal-title":"Circulation"},{"key":"1437_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11883-025-01320-z","volume":"27","author":"AB Abdul Jabbar","year":"2025","unstructured":"Abdul Jabbar AB, Inam M, Butt N, Khan SS, Sheikh S, Khoja A, et al. Predicting risk of cardiovascular disease EVENTs (PREVENT) equations: what clinicians need to know? Curr Atheroscler Rep. 2025;27:73 (Springer).","journal-title":"Curr Atheroscler Rep"},{"key":"1437_CR15","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1038\/s41591-025-03789-2","volume":"31","author":"RO Mathew","year":"2025","unstructured":"Mathew RO, Khan SS, Tuttle KR, Ho JE, Abramov D, Bangalore S, et al. Performance of the American heart association\u2019s PREVENT risk score for cardiovascular risk prediction in a multiethnic population. Nat Med. 2025;31:2655\u201362 (Nature Publishing Group US New York).","journal-title":"Nat Med."},{"key":"1437_CR16","doi-asserted-by":"publisher","first-page":"e266838","DOI":"10.1001\/jamanetworkopen.2026.6838","volume":"9","author":"C Hong","year":"2026","unstructured":"Hong C, Niu M, Wang H, Wojdyla DM, Economou-Zavlanos N, Engelhard MM, et al. Performance of PREVENT cardiovascular risk in electronic health record-based clinical practice. JAMA Netw Open. 2026;9:e266838 (American Medical Association).","journal-title":"JAMA Netw Open"},{"key":"1437_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.7326\/ANNALS-24-00074","volume":"177","author":"AMK Minhas","year":"2024","unstructured":"Minhas AMK, Virani SS, Michos ED, Nambi V, Blumenthal RS, Razavi AC, et al. Comparing cardiovascular risk classification of US adults according to pooled cohort equations and PREVENT equations: cross-sectional analysis of the national health and nutrition examination survey. Ann Intern Med. 2024;177:1444\u20138 (American College of Physicians).","journal-title":"Ann Intern Med"},{"key":"1437_CR18","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.jcmg.2022.02.026","volume":"15","author":"AC Razavi","year":"2022","unstructured":"Razavi AC, Agatston AS, Shaw LJ, De Cecco CN, van Assen M, Sperling LS, et al. Evolving role of calcium density in coronary artery calcium scoring and atherosclerotic cardiovascular disease risk. JACC Cardiovasc Imaging. 2022;15:1648\u201362.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1437_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/jamainternmed.2022.1262","volume":"182","author":"KJ Bell","year":"2022","unstructured":"Bell KJ, White S, Hassan O, Zhu L, Scott AM, Clark J, et al. Evaluation of the incremental value of a coronary artery calcium score beyond traditional cardiovascular risk assessment: a systematic review and meta-analysis. JAMA Intern Med. 2022;182:634\u201342.","journal-title":"JAMA Intern Med"},{"key":"1437_CR20","first-page":"1181","volume":"16","author":"MJ Budoff","year":"2023","unstructured":"Budoff MJ, Kinninger A, Gransar H, Achenbach S, Al-Mallah M, Bax JJ, et al. When does a calcium score equate to secondary prevention? Insights from the multinational CONFIRM registry. Cardiovasc Imaging. 2023;16:1181\u20139 (American College of Cardiology Foundation Washington DC).","journal-title":"Cardiovasc Imaging"},{"key":"1437_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","volume":"15","author":"CE Orringer","year":"2021","unstructured":"Orringer CE, Blaha MJ, Blankstein R, Budoff MJ, Goldberg RB, Gill EA, et al. The national lipid association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction. J Clin Lipidol. 2021;15:33\u201360.","journal-title":"J Clin Lipidol"},{"key":"1437_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2022.10.013","volume":"81","author":"LJ Laffin","year":"2023","unstructured":"Laffin LJ, Bruemmer D, Garcia M, Brennan DM, McErlean E, Jacoby DS, et al. Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers. J Am Coll Cardiol. 2023;81:1\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"1437_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120:229\u201343.","journal-title":"Circ Res"},{"key":"1437_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.2022.12138","volume":"328","author":"R Chou","year":"2022","unstructured":"Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, et al. Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2022;328:754\u201371.","journal-title":"JAMA"},{"key":"1437_CR25","doi-asserted-by":"publisher","first-page":"17014","DOI":"10.1038\/s41598-025-01930-2","volume":"15","author":"M Xie","year":"2025","unstructured":"Xie M, Martin SS, Turchin A. Reasons for non-acceptance of statin therapy by patients at high cardiovascular risk. Sci Rep. 2025;15:17014 (Nature Publishing Group UK London).","journal-title":"Sci Rep"},{"key":"1437_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.amjmed.2021.09.014","volume":"135","author":"SM Grundy","year":"2022","unstructured":"Grundy SM, Vega GL. Statin intolerance and noncompliance: an empiric approach. Am J Med. 2022;135:318\u201323.","journal-title":"Am J Med"},{"key":"1437_CR27","first-page":"544","volume":"25","author":"T Schleyer","year":"2019","unstructured":"Schleyer T, Hui S, Wang J, Zhang Z, Knapp K, Baker J, et al. Quantifying unmet need in statin-treated hyperlipidemia patients and the potential benefit of further LDL-C reduction through an EHR-based retrospective cohort study. J Manag Care Spec Pharm. 2019;25:544\u201354 (Academy of Managed Care Pharmacy).","journal-title":"J Manag Care Spec Pharm"},{"key":"1437_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009251","volume":"7","author":"AM Lowenstern","year":"2018","unstructured":"Lowenstern AM, Li S, Navar AM, Roger VL, Robinson JG, Goldberg AC, et al. Measurement of low\u2010density lipoprotein cholesterol levels in primary and secondary prevention patients: insights from the PALM registry. J Am Heart Assoc. 2018;7:e009251.","journal-title":"J Am Heart Assoc"},{"key":"1437_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s40256-025-00748-7","volume":"25","author":"T Mansoor","year":"2025","unstructured":"Mansoor T, Nambi V, Parikh S, Misra A, Ismayl M, Sullivan C, et al. Targeting triglycerides: the rise of Apolipoprotein C3 and Angiopoietin-Like protein 3 inhibitors: T. Mansoor et al. Am J Cardiovasc Drugs. 2025;25:749\u201366 (Springer).","journal-title":"Am J Cardiovasc Drugs"},{"key":"1437_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/14779072.2020.1717335","volume":"18","author":"D Mahtta","year":"2020","unstructured":"Mahtta D, Rodriguez F, Jneid H, Levine GN, Virani SS. Improving adherence to cardiovascular guidelines: realistic transition from paper to patient. Expert Rev Cardiovasc Ther. 2020;18:41\u201351 (Taylor & Francis).","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-026-01437-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:39:20Z","timestamp":1781494760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-026-01437-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1007\/s11883-026-01437-9","relation":{},"ISSN":["1534-6242"],"issn-type":[{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dmitry Abramov: speaker fees from AstraZeneca and BayerVera Bittner: Site PI for ORION IV (Novartis) and EVOLVE MI (Amgen); DSMB for Verve Therapeutics and Eli Lilly; Site PI for REHAB-HFpEF trial (study funded by NIA, UAB site funded through contract with Wake Forest); Editor, ACC SAP; Senior Guest Editor, CirculationSalim S. Virani: Research grants: NIH, UK NIHR, Tahir and Jooma Family, Asharia FamilyRemaining authors: noneDmitry Abramov: speaker fees from AstraZeneca and BayerVera Bittner: Site PI for ORION IV (Novartis) and EVOLVE MI (Amgen); DSMB for Verve Therapeutics and Eli Lilly; Site PI for REHAB-HFpEF trial (study funded by NIA, UAB site funded through contract with Wake Forest); Editor, ACC SAP; Senior Guest Editor, CirculationSalim S. Virani: Research grants: NIH, UK NIHR, Tahir and Jooma Family, Asharia FamilyRemaining authors: none","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No animal or human subjects by the authors were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"63"}}